Claudin-16 inactivating mutations in humans are associated with hypercalciuria and nephrocalcinosis55,56, possibly suggesting that significantly reduced claudin-16 expression in our studies might have contributed to the phenotype of vitamin D3-treated Npt2a−/− mice. This evidence concerns the gene CLDN16 and Hypercalciuria.